Breast cancer related lymphedema:from evaluation of risk to patient management

VernacularTitle:乳腺癌相关淋巴水肿:风险评估和预防管理
Author: Jiaqi HUANG ¹ ; Siyue ZHENG ; Qiwei ZHU ; Lu CAO ; Jiayi CHEN
Author Information

1. 上海交通大学医学院附属瑞金医院放射治疗科,上海 200025
Keywords: Breast cancer related lymphedema; Risk factors; Management for lymphedema
From: Tumor 2023;43(9):747-755
CountryChina
Language:Chinese
Abstract: Breast cancer-related lymphedema(BCRL)is one of the most common complications after multidiscipline treatment of breast cancer,which manifests as upper limb swelling and skin changes and significantly affects limb function and quality of life.The occurrence and development of BCRL are affected by many factors including surgery,radiotherapy,drugs,infection,trauma,and so on.Therefore,it is important to identify the potential risk factors to establish individualized prevention strategies.Evidence-based risk assessment models for BCRL could help clinicians to identify high-risk patients and apply prospective surveillance to treat BCRL at early stage.For patients with advanced lymphedema,conservative treatment and surgical treatment could be delivered to relieve symptoms and improve their conditions.This article comprehensively reviewed the risk factors,prospective surveillance,intervention,and research progress of BCRL,to provide reference for multidisciplinary collaboration as well as clinical diagnosis and treatment in this field.